These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1411963)

  • 1. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
    Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA
    Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of methods for analysis of clinical [11C]raclopride studies.
    Lammertsma AA; Bench CJ; Hume SP; Osman S; Gunn K; Brooks DJ; Frackowiak RS
    J Cereb Blood Flow Metab; 1996 Jan; 16(1):42-52. PubMed ID: 8530554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors.
    Mukherjee J; Yang ZY; Brown T; Roemer J; Cooper M
    Life Sci; 1996; 59(8):669-78. PubMed ID: 8761017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.
    Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP
    Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET.
    Opacka-Juffry J; Ashworth S; Ahier RG; Hume SP
    J Neural Transm (Vienna); 1998; 105(4-5):349-64. PubMed ID: 9720967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1999 Feb; 31(2):154-62. PubMed ID: 10024013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET.
    Hume SP; Opacka-Juffry J; Myers R; Ahier RG; Ashworth S; Brooks DJ; Lammertsma AA
    Synapse; 1995 Sep; 21(1):45-53. PubMed ID: 8525461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIC, an intracerebral beta(+)-range-sensitive probe for radiopharmacology investigations in small laboratory animals: binding studies with (11)C-raclopride.
    Zimmer L; Hassoun W; Pain F; Bonnefoi F; Lanièce P; Mastrippolito R; Pinot L; Pujol JF; Leviel V
    J Nucl Med; 2002 Feb; 43(2):227-33. PubMed ID: 11850489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects.
    Smith GS; Dewey SL; Brodie JD; Logan J; Vitkun SA; Simkowitz P; Schloesser R; Alexoff DA; Hurley A; Cooper T; Volkow ND
    Am J Psychiatry; 1997 Apr; 154(4):490-6. PubMed ID: 9090335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease.
    Rinne UK; Laihinen A; Rinne JO; Någren K; Bergman J; Ruotsalainen U
    Mov Disord; 1990; 5(1):55-9. PubMed ID: 2136932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study.
    Le Masurier M; Houston G; Cowen P; Grasby P; Sharp T; Hume S
    Synapse; 2004 Feb; 51(2):151-7. PubMed ID: 14618682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Schlyer DJ; Hitzemann R; Wolf AP
    Psychiatry Res; 1996 May; 67(1):11-6. PubMed ID: 8797238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
    Halldin C; Farde L; Högberg T; Hall H; Ström P; Ohlberger A; Solin O
    Int J Rad Appl Instrum B; 1991; 18(8):871-81. PubMed ID: 1839303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Synapse; 2000 Nov; 38(2):138-43. PubMed ID: 11018787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis.
    Dewey SL; Smith GS; Logan J; Alexoff D; Ding YS; King P; Pappas N; Brodie JD; Ashby CR
    J Neurosci; 1995 Jan; 15(1 Pt 2):821-9. PubMed ID: 7823183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.